BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15098092)

  • 1. [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].
    Weber MA; Risse F; Giesel FL; Schad LR; Kauczor HU; Essig M
    Radiologe; 2005 Jul; 45(7):618-32. PubMed ID: 15098092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
    Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours.
    Novak J; Withey SB; Lateef S; MacPherson L; Pinkey B; Peet AC
    Br J Radiol; 2019 Feb; 92(1094):20170872. PubMed ID: 30358415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional MRI procedures in the diagnosis of brain tumors: Perfusion- and diffusion-weighted imaging].
    Hartmann M; Heiland S; Sartor K
    Rofo; 2002 Aug; 174(8):955-64. PubMed ID: 12142971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
    Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
    Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
    Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
    Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    Huhndorf M; Moussavi A; Kramann N; Will O; Hattermann K; Stadelmann C; Jansen O; Boretius S
    PLoS One; 2016; 11(12):e0168174. PubMed ID: 28005983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib.
    Lucas JT; Knapp BJ; Uh J; Hua CH; Merchant TE; Hwang SN; Patay Z; Broniscer A
    Clin Neuroradiol; 2018 Sep; 28(3):393-400. PubMed ID: 28382379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging.
    Stokes AM; Skinner JT; Yankeelov T; Quarles CC
    Magn Reson Imaging; 2016 Nov; 34(9):1248-1255. PubMed ID: 27457801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
    Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
    Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
    Pillai JJ; Zacà D
    Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
    Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
    Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
    Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
    Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of arteriolar blood volume in brain tumors using MRI without exogenous contrast agent administration at 7T.
    Wu Y; Agarwal S; Jones CK; Webb AG; van Zijl PC; Hua J; Pillai JJ
    J Magn Reson Imaging; 2016 Nov; 44(5):1244-1255. PubMed ID: 27028493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.